Get started
Author

Salvatore Perrone

Observed names: Perrone, Salvatore, S. Perrone, S., Perrone, Salvatore PERRONE
Observed institutions: Policlinico Umberto I, IRCCS Ospedale San Raffaele, Ospedale Santa Maria Goretti, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, IRCCS San Raffaele Roma, Sapienza University of Rome
ORCID: 0000-0001-8196-0481
Observed ORCID: 0000-0001-8196-0481
OpenAlex ID: A5086920822
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
2021 · Matteo Molica, Salvatore Perrone, et al. · Cancers · 72
PDF
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
2019 · Andrés J. M. Ferreri, Teresa Calimeri, et al. · Blood · 54
PDF
Primary mediastinal lymphoma: diagnosis and treatment options
2014 · Maurizio Martelli, Alice Di Rocco, et al. · Expert Review of Hematology · 36
PDF
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era
2016 · Salvatore Perrone, Gianna Maria D’Elia, et al. · Leukemia Research · 34
Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-infective Therapy
2015 · Salvatore Perrone, Gianna Maria D'Elia, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 33
PDF
Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat FLT3-Mutated AML Patients
2023 · Matteo Molica, Salvatore Perrone, et al. · Journal of Clinical Medicine · 29
PDF
How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?
2023 · Salvatore Perrone, Tiziana Ottone, et al. · Cancer Drug Resistance · 27
New category of probable invasive pulmonary aspergillosis in haematological patients
2011 · C. Girmenia, P. Guerrisi, et al. · Clinical Microbiology and Infection · 27
Clarithromycin as a “repurposing drug” against MALT lymphoma
2017 · Andrés J. M. Ferreri, Caterina Cecchetti, et al. · British Journal of Haematology · 23
PDF
Leucocytosis during induction therapy with all‐trans‐retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment‐related complications
2024 · Laura Cicconi, Marialaura Bisegna, et al. · British Journal of Haematology · 18
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib
2021 · Salvatore Perrone, Elettra Ortu La Barbera, et al. · Chemotherapy · 18
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
2022 · Matteo Molica, Salvatore Perrone, et al. · Cancers · 17
PDF
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life
2021 · Pierantonio Menna, Emanuela Salvatorelli, et al. · Chemotherapy · 17
S trongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature
2014 · A.P. Iori, A. Ferretti, et al. · Transplant Infectious Disease · 17
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum
2020 · Andrés J. M. Ferreri, Marianna Sassone, et al. · Blood Advances · 16
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
2021 · Giovanni M. Assanto, Costantino Riemma, et al. · British Journal of Haematology · 14
PDF
Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K–Dependent Coagulation Factors Deficiency
2024 · Salvatore Perrone, Simona Raso, et al. · Seminars in Thrombosis and Hemostasis · 12
PDF
Real World Study on the Best CPX ‐351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation
2025 · Fabio Guolo, Luana Fianchi, et al. · American Journal of Hematology · 11
PDF
Proven E pstein– B arr encephalitis with negative EBV ‐ DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia
2014 · Walter Barberi, Salvatore Perrone, et al. · Pediatric Transplantation · 11
PDF
Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study
2025 · Matteo Dragani, Michela Ansuinelli, et al. · Haematologica · 10
PDF
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection
2011 · Giovanni F. Torelli, Barbarella Lucarelli, et al. · Leukemia Research · 10
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
2023 · Salvatore Perrone, Paolo Lopedote, et al. · Cancers · 9
PDF
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
2022 · Matteo Molica, Carla Mazzone, et al. · Cancers · 9
PDF
Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation
2020 · Andrés J. M. Ferreri, Marianna Sassone, et al. · Hematological Oncology · 8
Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.
2020 · Salvatore Perrone, Chiara Lisi, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 8
PDF
Works count: 92
Citation count: 667
H-index: 15
I10-index: 21
Year
Topic
Type